Lysigen is the subsidiary of PrecisioBiotix, a Cayman registered company.

Lysigen lead products are treatments for Eczema and Acne. Lysigen has its R&D center in Wuhan, China where it is developing novel lysin products.

Lysigen has significant IP and unique knowhow. In addition, Lysigen has a high-throughput LysiThru™ lysins screening technology platform, which can quickly and cost effectively develop novel lysins that target both gram-positive and gram-negative bacteria, including multi drug-resistant bacterial infections.